These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3428666)

  • 1. Bradykinin in carcinoid syndrome.
    Gustafsen J; Boesby S; Nielsen F; Giese J
    Gut; 1987 Nov; 28(11):1417-9. PubMed ID: 3428666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating bradykinin-like immunoreactivity and the pentagastrin-induced carcinoid flush.
    Balks HJ; Conlon JM; Creutzfeldt W; Stöckmann F
    Clin Endocrinol (Oxf); 1988 Aug; 29(2):141-51. PubMed ID: 3248356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cause of flushing in carcinoid syndrome.
    Mashford ML; Roberts ML
    Lancet; 1971 Oct; 2(7728):817. PubMed ID: 4106630
    [No Abstract]   [Full Text] [Related]  

  • 4. Histamine in carcinoid syndrome.
    Gustafsen J; Boesby S; Man WK
    Agents Actions; 1988 Aug; 25(1-2):1-3. PubMed ID: 3189038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Climacteric flushing in a patient with carcinoid tumour.
    Wilkin JK
    Br J Dermatol; 1985 Mar; 112(3):357-61. PubMed ID: 3978040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of adrenaline on blood kinin levels in carcinoid syndrome and in normal subjects.
    Mashford ML; Zacest R
    Australas Ann Med; 1967 Nov; 16(4):326-9. PubMed ID: 6080448
    [No Abstract]   [Full Text] [Related]  

  • 7. Tachykinins in carcinoid tumors: their use as a tumor marker and possible role in the carcinoid flush.
    Norheim I; Theodorsson-Norheim E; Brodin E; Oberg K
    J Clin Endocrinol Metab; 1986 Sep; 63(3):605-12. PubMed ID: 2426299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoid tumors and the carcinoid syndrome.
    Kazi MU; Grover V
    J Am Geriatr Soc; 1969 Aug; 17(8):807-16. PubMed ID: 5801424
    [No Abstract]   [Full Text] [Related]  

  • 9. Serotonin, catecholamines, and spontaneous midgut carcinoid flush: plasma studies from flushing and nonflushing sites.
    Matuchansky C; Launay JM
    Gastroenterology; 1995 Mar; 108(3):743-51. PubMed ID: 7533112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing features of idiopathic flushing and carcinoid syndrome.
    Aldrich LB; Moattari AR; Vinik AI
    Arch Intern Med; 1988 Dec; 148(12):2614-8. PubMed ID: 2461688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive peptides and the carcinoid syndrome.
    Goadsby PJ; Edvinsson L; Haber PS
    Ann Intern Med; 1988 Jun; 108(6):904. PubMed ID: 2453131
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of octreotide on basal and stimulated hormone levels in patients with carcinoid syndrome.
    Oberg K; Norheim I; Theodorsson E; Ahlman H; Lundqvist G; Wide L
    J Clin Endocrinol Metab; 1989 Apr; 68(4):796-800. PubMed ID: 2466045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological blockade of carcinoid flushing provoked by catecholamines and alcohol.
    Adamson AR; Grahame-Smith DG; Peart WS
    Am Heart J; 1971 Jan; 81(1):141-2. PubMed ID: 5539992
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients.
    Ruszniewski P; Ducreux M; Chayvialle JA; Blumberg J; Cloarec D; Michel H; Raymond JM; Dupas JL; Gouerou H; Jian R; Genestin E; Bernades P; Rougier P
    Gut; 1996 Aug; 39(2):279-83. PubMed ID: 8977344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flushing in the carcinoid syndrome and plasma kallikrein.
    Lucas KJ; Feldman JM
    Cancer; 1986 Nov; 58(10):2290-3. PubMed ID: 2428458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulation of a fragment of haemoglobin alpha-chain during a pentagastrin-induced flush in patients with metastatic carcinoid tumours.
    Balks HJ; Thim L; Conlon JM
    Clin Endocrinol (Oxf); 1988 Mar; 28(3):261-9. PubMed ID: 3168309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudocarcinoid syndrome associated with hypogonadism and response to testosterone therapy.
    Shakir KM; Jasser MZ; Yoshihashi AK; Drake AJ; Eisold JF
    Mayo Clin Proc; 1996 Dec; 71(12):1145-9. PubMed ID: 8945484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study.
    Ruszniewski P; Valle JW; Lombard-Bohas C; Cuthbertson DJ; Perros P; Holubec L; Delle Fave G; Smith D; Niccoli P; Maisonobe P; Atlan P; Caplin ME;
    Dig Liver Dis; 2016 May; 48(5):552-558. PubMed ID: 26917486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for coronary spasm during flushing in the carcinoid syndrome.
    Petersen KG; Seemann WR; Plagwitz R; Kerp L
    Clin Cardiol; 1984 Aug; 7(8):445-8. PubMed ID: 6467696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.
    Long RG; Peters JR; Bloom SR; Brown MR; Vale W; Rivier JE; Grahame-Smith DG
    Gut; 1981 Jul; 22(7):549-53. PubMed ID: 6114901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.